Hem › Burkitts lymfom › New Mexico › Albuquerque
Kliniska studier för Burkitts lymfom i Albuquerque, NM
3 studier för Burkitts lymfom söker deltagare vid platser i och runt Albuquerque (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekryterarFas 2
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekryterarFas 2
- Presbyterian Hospital, Albuquerque
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekryterarFas 3
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
Burkitts lymfom-studier i andra städer
- Houston, TX21 studier
- Philadelphia, PA16 studier
- Milwaukee, WI16 studier
- Chicago, IL15 studier
- Cincinnati, OH13 studier
- New York City, NY13 studier
- Atlanta, GA12 studier
- Aurora, CO11 studier
- Seattle, WA11 studier
- Durham, NC10 studier
- Boston, MA10 studier
- Kansas City, MO10 studier
Andra studier i Albuquerque
- Icke-småcellig lungcancer18 studier
- Bröstcancer17 studier
- Äggstockscancer15 studier
- Cancer (alla typer)14 studier
- Lungcancer14 studier
- Metastaserande cancer12 studier
- Endometriecancer12 studier
- Typ 2-diabetes11 studier
- Hjärt-kärlsjukdom10 studier
- Melanom9 studier
- Akut myeloid leukemi9 studier
- Prostatacancer9 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.